C2ORF68 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.284420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.397000E-01
Normal-vs-Stage2
1.331610E-01
Normal-vs-Stage3
5.366000E-02
Normal-vs-Stage4
6.247800E-01
Stage1-vs-Stage2
4.283800E-01
Stage1-vs-Stage3
1.315640E-02
Stage1-vs-Stage4
6.125800E-01
Stage2-vs-Stage3
7.523600E-02
Stage2-vs-Stage4
3.012200E-01
Stage3-vs-Stage4
2.663700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.314630E-01
Normal-vs-AfricanAmerican
1.288790E-01
Normal-vs-Asian
3.651400E-01
Caucasian-vs-AfricanAmerican
5.522000E-01
Caucasian-vs-Asian
6.610200E-01
AfricanAmerican-vs-Asian
5.005200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.113550E-01
Normal-vs-Female
1.634430E-01
Male-vs-Female
9.088200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.039600E-01
Normal-vs-Age(41-60Yrs)
2.717800E-01
Normal-vs-Age(61-80Yrs)
9.049900E-02
Normal-vs-Age(81-100Yrs)
6.168100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.760400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.887600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.176640E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.737700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.760600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.834600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.274170E-01
Normal-vs-Daily Drinker
1.235410E-01
Normal-vs-Weekly Drinker
1.111830E-01
Normal-vs-Occasional Drinker
5.087000E-01
Normal-vs-Social Drinker
6.826200E-01
Non Drinker-vs-Daily Drinker
9.860200E-01
Non Drinker-vs-Weekly Drinker
4.748200E-01
Non Drinker-vs-Occasional Drinker
1.764610E-01
Non Drinker-vs-Social Drinker
9.620500E-02
Daily Drinker-vs-Weekly Drinker
4.791600E-01
Daily Drinker-vs-Occasional Drinker
2.041200E-01
Daily Drinker-vs-Social Drinker
1.176360E-01
Weekly Drinker-vs-Occasional Drinker
1.091370E-01
Weekly Drinker-vs-Social Drinker
7.509500E-02
Occasional Drinker-vs-Social Drinker
7.207600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.431900E-02
Normal-vs-Grade 2
9.242200E-04
Normal-vs-Grade 3
7.079600E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.143200E-01
Grade 1-vs-Grade 3
1.367830E-01
Grade 1-vs-Grade 4
5.431900E-02
Grade 2-vs-Grade 3
1.194200E-01
Grade 2-vs-Grade 4
9.242200E-04
Grade 3-vs-Grade 4
7.079600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.321900E-02
Normal-vs-NonDiabetic
1.896000E-01
Diabetic-vs-NonDiabetic
2.207200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.010400E-01
Normal-vs-NoPancreatitis
1.066390E-01
Pancreatitis-vs-NoPancreatitis
5.831900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.819000E-01
Normal-vs-N1
8.229600E-02
N0-vs-N1
1.222760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.539800E-01
Normal-vs-TP53-NonMutant
2.961200E-01
TP53-Mutant-vs-TP53-NonMutant
9.935700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
